You can:
Name | Gastrin-releasing peptide receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | GRPR |
Synonym | GRP-R GRP-preferring bombesin receptor gastrin-releasing peptide receptor BB2 receptor BB2 |
Disease | Solid tumours Breast cancer Cancer Irritable bowel syndrome |
Length | 384 |
Amino acid sequence | MALNDCFLLNLEVDHFMHCNISSHSADLPVNDDWSHPGILYVIPAVYGVIILIGLIGNITLIKIFCTVKSMRNVPNLFISSLALGDLLLLITCAPVDASRYLADRWLFGRIGCKLIPFIQLTSVGVSVFTLTALSADRYKAIVRPMDIQASHALMKICLKAAFIWIISMLLAIPEAVFSDLHPFHEESTNQTFISCAPYPHSNELHPKIHSMASFLVFYVIPLSIISVYYYFIAKNLIQSAYNLPVEGNIHVKKQIESRKRLAKTVLVFVGLFAFCWLPNHVIYLYRSYHYSEVDTSMLHFVTSICARLLAFTNSCVNPFALYLLSKSFRKQFNTQLLCCQPGLIIRSHSTGRSTTCMTSLKSTNPSVATFSLINGNICHERYV |
UniProt | P30550 |
Protein Data Bank | N/A |
GPCR-HGmod model | P30550 |
3D structure model | This predicted structure model is from GPCR-EXP P30550. |
BioLiP | N/A |
Therapeutic Target Database | T99816 |
ChEMBL | CHEMBL4959 |
IUPHAR | 39 |
DrugBank | N/A |
Name | CHEMBL3909253 |
---|---|
Molecular formula | C70H110N22O19S2 |
IUPAC name | (3S)-3-[[2-[4-[2-[[2-[[(2R)-3-(acetamidomethylsulfanyl)-2-[[(2S)-2-[[2-(dimethylamino)acetyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]acetyl]amino]ethyl]piperazin-1-yl]acetyl]amino]-4-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-oxobutanoic acid |
Molecular weight | 1627.91 |
Hydrogen bond acceptor | 25 |
Hydrogen bond donor | 20 |
XlogP | -6.7 |
Synonyms | N/A |
Inchi Key | GXCZZATWOZASHE-WIRSSUKHSA-N |
Inchi ID | InChI=1S/C70H110N22O19S2/c1-38(2)24-48(66(107)84-46(61(72)102)16-23-112-9)86-67(108)50(26-43-29-73-36-78-43)81-56(97)31-77-70(111)60(39(3)4)89-62(103)40(5)80-65(106)49(25-42-28-75-45-13-11-10-12-44(42)45)87-64(105)47(14-15-54(71)95)85-68(109)51(27-59(100)101)82-58(99)33-92-21-19-91(20-22-92)18-17-74-55(96)30-76-63(104)53(35-113-37-79-41(6)94)88-69(110)52(34-93)83-57(98)32-90(7)8/h10-13,28-29,36,38-40,46-53,60,75,93H,14-27,30-35,37H2,1-9H3,(H2,71,95)(H2,72,102)(H,73,78)(H,74,96)(H,76,104)(H,77,111)(H,79,94)(H,80,106)(H,81,97)(H,82,99)(H,83,98)(H,84,107)(H,85,109)(H,86,108)(H,87,105)(H,88,110)(H,89,103)(H,100,101)/t40-,46-,47-,48-,49-,50-,51-,52-,53-,60-/m0/s1 |
PubChem CID | 134132331 |
ChEMBL | CHEMBL3909253 |
IUPHAR | N/A |
BindingDB | N/A |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
IC50 | <50.0 nM | None | ChEMBL |
zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218